London, United Kingdom
Wed 27 11:00
CME2.1
Bristol, United Kingdom
Thu 28 11:30
DS2.1
Managing Diabetes in Special Circumstances - Caring for type 1 diabetes in socially deprived and BEM groups of children
London, UK
Thu 28 09:00
DS1.1
Practical Diabetes - Nutrition, food science and cooking – what role in management of diabetes in children?
London, UK
Thu 28 13:42
OC5.3
Causes of Central Diabetes Insipidus in Children: A Single-Centre Experience
Wed 27 10:00
OC1.1
Exploring Trends in the Glucocorticoid and Mineralocorticoid Treatment of Congenital Adrenal Hyperplasia by Analysing Data from the I-CAH Registry
Thu 28 10:20
OC4.9
Health Status of Children Aged 8-18 Years with 21-Hydroxylase Deficiency in the United Kingdom: Results of a Multi-Centre Cohort Study
Birmingham, UK
Fri 29 10:30
S3.3
Diabetes Trials - Novel therapies for type 2 diabetes
Birmingham, UK
Oxford, UK
Thu 28 14:30
D1.1
Diabetes Debate: For the Motion - "This House believes that continuity of care with doctors underpins optimal diabetes management in children and young people with diabetes"
Oxford, UK
Oxford, UK
Thu 28 14:24
OC5.10
Review of neonatal cortisol evaluation between 2012-2018 in a single centre: trends, outcomes and associations.
Oxford, UK
UK
Thu 28 09:10
OC4.2
Burosumab Initiation in a UK XLH Cohort: Real-World Use Resonates With Research Evidence
UK
Leeds Children's Hospital, The Leeds Teaching Hospitals NHS Trust, Leeds, UK
Wed 27 14:30
OC3.1
Using Quality Improvement Methods to Enhance HbA1c Outcomes for Newly Diagnosed Children and Young People with Diabetes
Leeds Children's Hospital, The Leeds Teaching Hospitals NHS Trust, Leeds, UK
Wed 27 16:00
CME4.2
Promoting optimal self-management in type 1 diabetes – what can we offer?
Leeds Children's Hospital, The Leeds Teaching Hospitals NHS Trust, Leeds, UK
Cardiff, UK
Thu 28 14:00
DS3.2
Enhancing Diabetes Care - Type 2 diabetes, an increasing problem: lessons from national surveys
Cardiff, UK
Bristol, UK
Thu 28 10:00
OC4.7
Novel variants in the Leucine-zipper-like transcription regulator 1 (LZTR1) gene cause Noonan syndrome phenotype by upregulation of the RAS-MAPKinase pathway
Bristol, UK
Newcastle, UK
Thu 28 14:30
IN1
Fri 29 14:45
S5.2
Dose titration vs block and replace - the evidence in thyrotoxicosis
Newcastle, UK
Thu 28 12:00
DS2.2
Managing Diabetes in Special Circumstances - Avoiding hypoglycaemia during sporting activity
London, UK
Fri 29 12:00
ND2.1
Assessing and monitoring growth in children with bone disorders
London, UK
Thu 28 09:30
DS1.2
Practical Diabetes - Using 'Carbs and Cals' in everyday practice
Thu 28 11:24
OC6.5
Factors affecting the practice of routinely downloading blood glucose data at home for families and children with Type 1 Diabetes
London, UK
Wed 27 12:15
OC2.2
Thu 28 09:40
OC4.5
Novel genetic defects in a cohort of Silver-Russell Syndrome (SRS) and SRS-like patients
London, UK
Cardiff, Wales
Fri 29 09:30
S3.1
Fri 29 11:50
OC7.3
Improving HbA1c Outcomes in Young People of Transition Age with Type 1 Diabetes Using Quality Improvement Methodology
Cardiff`, UK
Thu 28 09:50
OC4.6
Understanding Differences of Sexual Differentiation (DSD) MDT services across the UK; current service provision and sharing best practice
Cardiff`, UK
Fri 29 11:30
OC8.1
Random cortisols – as useful as a chocolate teapot (but less tasty)?
Fri 29 10:30
PENS1.3
London, UK
Wed 27 12:00
OC2.1
National United Kingdom evidence- and consensus-based guidelines for the investigation, treatment and long-term follow-up of paediatric craniopharyngioma
London, UK
London, UK
Fri 29 12:30
OC7.7
Paediatric Type 2 diabetes in a single centre in East London in the period 2009-2018
London, UK
Thu 28 13:48
OC5.4
Tolvaptan for Hyponatraemia in Infants with Brain Tumours
UK
Fri 29 11:30
OC7.1
Increased and younger alcohol-related hospital admissions in young people with childhood-onset type-1 diabetes: a record-linked longitudinal population study in Wales
UK
Fri 29 15:15
S4.3
London, UK
Thu 28 09:20
OC4.3
Defects in LGR4 Wnt-β-catenin signalling impair GnRH network development, leading to delayed puberty
London, UK
Fri 29 11:54
OC8.5
The impact of Prader-Willi Syndrome Multidisciplinary clinic on growth parameters
Wed 27 14:45
OC3.2
2 year experience of 'Do-It-Yourself' Hybrid Closed Loop in an adolescent with Type 1 Diabetes
Southport , UK
Thu 28 13:36
OC5.2
Longitudinal outcomes of well, term infants who present with persistent hyperthyrotropinaemia
Southport , UK
Fri 29 12:50
OC7.9
Does having a first degree relative with Type1 Diabetes impact on a child and family’s engagement and glycaemic control?
Thu 28 14:06
OC5.7
Longitudinal Changes in External Masculinisation Scores in Boys Born with XY Disorders of Sex Development
Sheffield, UK
London, UK
Fri 29 14:15
S5.1
Thyroid surgery in children: Why, When, How and Who
London, UK
Thu 28 09:30
OC4.4
A Novel Clinical Risk Score That Accurately Predicts Recurrence of Craniopharyngioma - a Multicentre Cohort Study.
Thu 28 14:12
OC5.8
TSH-Receptor testing in pregnancy allows stratification of risk of neonatal thyrotoxicosis and promotes earlier discharge
Cardiff, UK
Thu 28 12:00
S1.3
Endocrine Outcomes - Maternal thyroid function in pregnancy and childhood outcomes
Cardiff, UK
Fri 29 14:45
S4.2
Improving Diabetes Care - QI in action - the Sheffield Children's Hospital experience
Thu 28 10:10
OC4.8
SGPL1 deficiency leads to accumulation of sphingolipid species and downregulation of key enzymes within the steroidogenic pathway
Fri 29 11:48
OC8.4
Optimising Transition Care in Endocrinology: an example of patient-focused quality improvement.
Fri 29 12:10
OC7.5
Medication adherence during adjunct therapy with statins and ACE inhibitors in adolescents with type 1 diabetes
Manchester, UK
Wed 27 13:30
CME3.1
Thu 28 14:30
D1.2
Diabetes Debate: Against the Motion - "This House believes that continuity of care with doctors underpins optimal diabetes management in children and young people with diabetes"
Wed 27 10:15
OC1.2
Pituitary Apoplexy in an adolescent male with Macroprolactinoma presenting as middle cerebral artery infarction.
UK
Thu 28 13:30
DS3.1
Enhancing Diabetes Care - Getting the best out of social media in paediatric diabetes
UK
Fri 29 10:00
PENS1.2
Liverpool, UK
Fri 29 12:00
OC7.4
Monitoring lipid profiles in children and young people with Type 1 Diabetes Mellitus: What should we do with these results?
Liverpool, UK
Fri 29 09:30
PENS1.1
PENS - Emergency care of infants with cortisol deficiency: the paramedic perspective
Cardiff, UK
Thu 28 10:00
DS1.3
Practical Diabetes - Disordered eating and Type 1 diabetes
Cardiff, UK
London, UK
Thu 28 13:54
OC5.5
Recombinant human Insulin-like growth factor-1 (rhIGF-1) therapy: a 15-year experience in a tertiary care centre
London, UK
Thu 28 14:18
OC5.9
Rare causes of primary adrenal insufficiency (PAI) in children from Sudan
Fri 29 11:42
OC8.3
Specially Identified Patients (SIPs) – How do they work?
Cardiff University, United Kingdom
Thu 28 11:00
S1.1
Endocrine Outcomes - Long term outcomes for young women with PCOS
Cardiff University, United Kingdom
Cambridge, United Kingdom
Fri 29 15:15
S5.3
Congenital TSH deficiency
Cambridge, United Kingdom
Fri 29 12:20
OC7.6
Improving referral pathways from primary to secondary care in newly diagnosed Type 1 diabetes
Thu 28 11:12
OC6.3
Here’s the POInT: a multicentre European Primary Oral Insulin Trial.
Thu 28 11:06
OC6.2
An exploration of the perceptions and lived experience of primary school aged children using insulin pump therapy
Thu 28 11:30
S1.2
Endocrine Outcomes - Have modern treatment regimens improved neuroendocrine and cognitive outcomes after childhood brain tumours ?
Sheffield, UK
Thu 28 07:45
Fluid restriction in the management DKA in an intensive care setting - has the pendulum swung too far?
Sheffield, UK
Thu 28 14:00
OC5.6
Monitoring and long-term disease activity in children with X-linked hypophosphataemia on conventional therapy
Fri 29 12:40
OC7.8
Children with type 1 diabetes on intensive insulin, in deprived areas and younger onset are at risk of being overweight.
Oxford, United Kingdom
Thu 28 16:00
S2.1
Norwich, UK
Fri 29 11:36
OC8.2
Adrenal Insufficiency: hydrocortisone prescribing and sick day rules
Norwich, UK
Thu 28 13:30
OC5.1
Project to Develop BSPED UK Standardised Guidelines for Sex Hormone Priming and Glucagon Stimulation Testing (GST) in Children and Adolescents
Fri 29 10:00
S3.2
Diabetes Trials - Role of the environment in the pathogenesis of Type 1 diabetes
Glasgow, UK
Fri 29 12:00
ND2.2
Endocrine management in Duchenne muscular dystrophy?
Glasgow, UK
Fri 29 14:15
S4.1
Sheffield
Thu 28 08:15
Management of DKA - Evidence and Consensus recommendations for the proposed changes to the management of DKA and to the BSPED Guidelines
Sheffield
Thu 28 11:18
OC6.4
Exam Preparedness in Students with Type 1 Diabetes and their Schools – a Quality Improvement Study
No focus area defined
Workshop
7
Oral
8
Expert
7
Plenary
1
Catering and Social
8
Nurse
6
Other
7
Symposium
5
No Session Type
0
Thu 28 09:00
DS1.1
Practical Diabetes - Nutrition, food science and cooking – what role in management of diabetes in children?
London, UK
Thu 28 09:30
DS1.2
Practical Diabetes - Using 'Carbs and Cals' in everyday practice
Thu 28 10:00
DS1.3
Practical Diabetes - Disordered eating and Type 1 diabetes
Cardiff, UK
Thu 28 11:00
OC6.1
A survey into the care of children with type 2 diabetes in England and Wales
Thu 28 11:06
OC6.2
An exploration of the perceptions and lived experience of primary school aged children using insulin pump therapy
Thu 28 11:12
OC6.3
Here’s the POInT: a multicentre European Primary Oral Insulin Trial.
Thu 28 11:18
OC6.4
Exam Preparedness in Students with Type 1 Diabetes and their Schools – a Quality Improvement Study
Thu 28 11:24
OC6.5
Factors affecting the practice of routinely downloading blood glucose data at home for families and children with Type 1 Diabetes
Thu 28 11:30
DS2.1
Managing Diabetes in Special Circumstances - Caring for type 1 diabetes in socially deprived and BEM groups of children
Thu 28 12:00
DS2.2
Managing Diabetes in Special Circumstances - Avoiding hypoglycaemia during sporting activity
Thu 28 13:30
DS3.1
Enhancing Diabetes Care - Getting the best out of social media in paediatric diabetes
UK
Thu 28 14:00
DS3.2
Enhancing Diabetes Care - Type 2 diabetes, an increasing problem: lessons from national surveys
Cardiff, UK
Thu 28 14:30
D1.1
Diabetes Debate: For the Motion - "This House believes that continuity of care with doctors underpins optimal diabetes management in children and young people with diabetes"
Oxford, UK
Thu 28 14:30
D1.2
Diabetes Debate: Against the Motion - "This House believes that continuity of care with doctors underpins optimal diabetes management in children and young people with diabetes"
Fri 29 09:30
S3.1
Fri 29 10:00
S3.2
Diabetes Trials - Role of the environment in the pathogenesis of Type 1 diabetes
Fri 29 10:30
S3.3
Diabetes Trials - Novel therapies for type 2 diabetes
Birmingham, UK
Fri 29 14:15
S4.1
Fri 29 14:45
S4.2
Improving Diabetes Care - QI in action - the Sheffield Children's Hospital experience
Fri 29 15:15
S4.3
Wed 27 10:00
OC1.1
Exploring Trends in the Glucocorticoid and Mineralocorticoid Treatment of Congenital Adrenal Hyperplasia by Analysing Data from the I-CAH Registry
Wed 27 10:15
OC1.2
Pituitary Apoplexy in an adolescent male with Macroprolactinoma presenting as middle cerebral artery infarction.
Wed 27 12:00
OC2.1
National United Kingdom evidence- and consensus-based guidelines for the investigation, treatment and long-term follow-up of paediatric craniopharyngioma
London, UK
Wed 27 12:15
OC2.2
Wed 27 14:30
OC3.1
Using Quality Improvement Methods to Enhance HbA1c Outcomes for Newly Diagnosed Children and Young People with Diabetes
Leeds Children's Hospital, The Leeds Teaching Hospitals NHS Trust, Leeds, UK
Wed 27 14:45
OC3.2
2 year experience of 'Do-It-Yourself' Hybrid Closed Loop in an adolescent with Type 1 Diabetes
Thu 28 09:10
OC4.2
Burosumab Initiation in a UK XLH Cohort: Real-World Use Resonates With Research Evidence
UK
Thu 28 09:20
OC4.3
Defects in LGR4 Wnt-β-catenin signalling impair GnRH network development, leading to delayed puberty
London, UK
Thu 28 09:30
OC4.4
A Novel Clinical Risk Score That Accurately Predicts Recurrence of Craniopharyngioma - a Multicentre Cohort Study.
Thu 28 09:40
OC4.5
Novel genetic defects in a cohort of Silver-Russell Syndrome (SRS) and SRS-like patients
London, UK
Thu 28 09:50
OC4.6
Understanding Differences of Sexual Differentiation (DSD) MDT services across the UK; current service provision and sharing best practice
Cardiff`, UK
Thu 28 10:00
OC4.7
Novel variants in the Leucine-zipper-like transcription regulator 1 (LZTR1) gene cause Noonan syndrome phenotype by upregulation of the RAS-MAPKinase pathway
Bristol, UK
Thu 28 10:10
OC4.8
SGPL1 deficiency leads to accumulation of sphingolipid species and downregulation of key enzymes within the steroidogenic pathway
Thu 28 10:20
OC4.9
Health Status of Children Aged 8-18 Years with 21-Hydroxylase Deficiency in the United Kingdom: Results of a Multi-Centre Cohort Study
Thu 28 13:30
OC5.1
Project to Develop BSPED UK Standardised Guidelines for Sex Hormone Priming and Glucagon Stimulation Testing (GST) in Children and Adolescents
Thu 28 13:36
OC5.2
Longitudinal outcomes of well, term infants who present with persistent hyperthyrotropinaemia
Southport , UK
Thu 28 13:42
OC5.3
Causes of Central Diabetes Insipidus in Children: A Single-Centre Experience
Thu 28 13:48
OC5.4
Tolvaptan for Hyponatraemia in Infants with Brain Tumours
Thu 28 13:54
OC5.5
Recombinant human Insulin-like growth factor-1 (rhIGF-1) therapy: a 15-year experience in a tertiary care centre
London, UK
Thu 28 14:00
OC5.6
Monitoring and long-term disease activity in children with X-linked hypophosphataemia on conventional therapy
Thu 28 14:06
OC5.7
Longitudinal Changes in External Masculinisation Scores in Boys Born with XY Disorders of Sex Development
Thu 28 14:12
OC5.8
TSH-Receptor testing in pregnancy allows stratification of risk of neonatal thyrotoxicosis and promotes earlier discharge
Thu 28 14:18
OC5.9
Rare causes of primary adrenal insufficiency (PAI) in children from Sudan
Thu 28 14:24
OC5.10
Review of neonatal cortisol evaluation between 2012-2018 in a single centre: trends, outcomes and associations.
Oxford, UK
Fri 29 11:30
OC7.1
Increased and younger alcohol-related hospital admissions in young people with childhood-onset type-1 diabetes: a record-linked longitudinal population study in Wales
UK
Fri 29 11:40
OC7.2
Impact of Continuous Glucose Monitoring on Sleep Quality in Children with Type 1 Diabetes and their Parents: A Pilot Study
Fri 29 11:50
OC7.3
Improving HbA1c Outcomes in Young People of Transition Age with Type 1 Diabetes Using Quality Improvement Methodology
Fri 29 12:00
OC7.4
Monitoring lipid profiles in children and young people with Type 1 Diabetes Mellitus: What should we do with these results?
Liverpool, UK
Fri 29 12:10
OC7.5
Medication adherence during adjunct therapy with statins and ACE inhibitors in adolescents with type 1 diabetes
Fri 29 12:20
OC7.6
Improving referral pathways from primary to secondary care in newly diagnosed Type 1 diabetes
Fri 29 12:30
OC7.7
Paediatric Type 2 diabetes in a single centre in East London in the period 2009-2018
London, UK
Fri 29 12:40
OC7.8
Children with type 1 diabetes on intensive insulin, in deprived areas and younger onset are at risk of being overweight.
Fri 29 12:50
OC7.9
Does having a first degree relative with Type1 Diabetes impact on a child and family’s engagement and glycaemic control?
Fri 29 11:30
OC8.1
Random cortisols – as useful as a chocolate teapot (but less tasty)?
Fri 29 11:36
OC8.2
Adrenal Insufficiency: hydrocortisone prescribing and sick day rules
Norwich, UK
Fri 29 11:42
OC8.3
Specially Identified Patients (SIPs) – How do they work?
Fri 29 11:48
OC8.4
Optimising Transition Care in Endocrinology: an example of patient-focused quality improvement.
Fri 29 11:54
OC8.5
The impact of Prader-Willi Syndrome Multidisciplinary clinic on growth parameters
Thu 28 07:45
Fluid restriction in the management DKA in an intensive care setting - has the pendulum swung too far?
Sheffield, UK
Thu 28 08:15
Management of DKA - Evidence and Consensus recommendations for the proposed changes to the management of DKA and to the BSPED Guidelines
Sheffield
Thu 28 11:00
S1.1
Endocrine Outcomes - Long term outcomes for young women with PCOS
Cardiff University, United Kingdom
Thu 28 11:30
S1.2
Endocrine Outcomes - Have modern treatment regimens improved neuroendocrine and cognitive outcomes after childhood brain tumours ?
Thu 28 12:00
S1.3
Endocrine Outcomes - Maternal thyroid function in pregnancy and childhood outcomes
Cardiff, UK
Thu 28 14:30
IN1
Thu 28 16:00
S2.1
Fri 29 09:30
PENS1.1
PENS - Emergency care of infants with cortisol deficiency: the paramedic perspective
Fri 29 10:00
PENS1.2
Fri 29 10:30
PENS1.3
Fri 29 12:00
ND2.2
Endocrine management in Duchenne muscular dystrophy?
Glasgow, UK
Fri 29 12:00
ND2.1
Assessing and monitoring growth in children with bone disorders
London, UK
Fri 29 14:15
S5.1
Thyroid surgery in children: Why, When, How and Who
London, UK
Fri 29 14:45
S5.2
Dose titration vs block and replace - the evidence in thyrotoxicosis
Newcastle, UK
Fri 29 15:15
S5.3
Congenital TSH deficiency
Cambridge, United Kingdom
0 result(s) found.